Relief Therapeutics Holding AG (RLF) — Cash Flow Reinvestment Rate

Latest as of December 2024: 0.04x

Relief Therapeutics Holding AG (RLF) has a Cash Flow Reinvestment Rate of 0.04x as of December 2024, reinvesting CHF14.00K (capex CHF14.00K ) from operating cash flow of CHF359.00K. Check cash flow quality index of Relief Therapeutics Holding AG to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.04x
(Capex + Investments) / Operating CF

Total Reinvested

CHF14.00K
Capex + Investments

Operating Cash Flow

CHF359.00K
CHF

Capital Expenditures

CHF14.00K
CHF

Relief Therapeutics Holding AG Cash Flow Reinvestment Rate (2006–2006)

Historical reinvestment intensity for Relief Therapeutics Holding AG across 1 annual periods. Explore RLF debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Relief Therapeutics Holding AG (2006–2006)

Year-by-year capital reinvestment analysis for Relief Therapeutics Holding AG. For live market cap and broader valuation context, see Relief Therapeutics Holding AG market cap and net worth.

Year Reinvestment Rate Total Reinvested (CHF) Operating CF Capex YoY Change
2006 0.21x CHF474.60K CHF2.28 Million CHF474.60K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow